Theriva Biologicsincis A Clinical Stage Immuno Oncology Company Dedicated To Developing Innovative Therapeutics For Cancer And Related Diseasesthe Company Focuses On Oncolytic Viruses That Target Solid Tumorsaiming To Enhance The Effectiveness Of Existing Cancer Treatmentstheriva Is Listed On The Nyse American Under The Ticker Symbol Tovx The Companyae S Lead Candidates Include Vcn 01An Oncolytic Adenovirus Designed To Selectively Replicate Within Tumor Cells And Break Down The Tumor Stroma Barrierother Products Include Syn 004Ribaxamase Which Protects The Microbiome During Antibiotic Treatmentand Syn 020An Oral Formulation Intended For Gastrointestinal And Systemic Diseasestheriva Is Also Exploring Additional Technologies To Further Its Mission Of Improving Patient Outcomes In Difficult To Treat Cancersled By A Team Of Experienced Professionalstheriva Biologics Is Committed To Advancing Cancer Therapies And Is Actively Seeking Talented Individuals To Join Their Efforts In Transforming Cancer Treatment
No conferences found for this company.
| Company Name | Therion Biologics Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
